PD-1 INHIBITOR
Clinical trials for PD-1 INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PD-1 INHIBITOR trials appear
Sign up with your email to follow new studies for PD-1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation combo shows promise for tough lung cancers
Disease control OngoingThis early-phase study tests whether combining low-dose radiation with targeted radiation (SBRT) and an immunotherapy drug (PD-1 inhibitor) is safe for people with advanced non-small cell lung cancer who have not responded to standard treatments. Nine participants will receive th…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 17, 2026 01:36 UTC
-
New drug combo shows promise for advanced throat cancer
Disease control OngoingThis study tests whether adding an immunotherapy drug (PD-1 inhibitor) to chemotherapy before standard treatment can help people with advanced nasopharyngeal cancer live longer without the disease getting worse. About 150 adults with stage T4 or N2-3 cancer will receive either th…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 17, 2026 01:35 UTC
-
Gut bacteria boosts cancer immunotherapy in early trial
Disease control OngoingThis early-phase study tests whether taking a specific probiotic (Akkermansia) alongside an immunotherapy drug (anti-PD-1) is safe and feasible for people with advanced colorectal cancer that hasn't responded to standard treatments. The trial involves 22 adults aged 18-75. Resear…
Matched conditions: PD-1 INHIBITOR
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated May 13, 2026 16:01 UTC